Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc...

6
1 Patient Selection IOL Power Calculation Verisyse™ and VeriFlex™ Iris Claw Technology for Correcting Refractive Errors in Phakic and Aphakic Eyes ESCRS 2011 Intructional Course 61 Patient Selection IOL Power Calculation Verisyse™ and VeriFlex™ Iris Claw Technology for Correcting Refractive Errors in Phakic and Aphakic Eyes ESCRS 2011 Intructional Course 61 Josef Ruckhofer Josef Ruckhofer Josef Ruckhofer Josef Ruckhofer University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010 Verisyse™ and VeriFlex™ Verisyse™ and VeriFlex™ Patient Selection Refraction History General Ocular Social Exclusion Criteria Preop Examination ACD Pupil Size Planning Surgery Biometry IOL-Power calculation using Vericalc 2.0 Patient Selection Refraction History General Ocular Social Exclusion Criteria Preop Examination ACD Pupil Size Planning Surgery Biometry IOL-Power calculation using Vericalc 2.0 University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010 Patient Selection for Verisyse/Veriflex Patient Selection for Verisyse/Veriflex Refraction stable ± 0.5 D within 2 years Myopia - 1.0 up to - 23.5 D (5 mm optic) - 1.0 up to - 15.5 D (6 mm optic) - 2.0 up to - 14.5 D (Veriflex) Hyperopia + 1.0 to +12.0 D Astigmatism 1 to 7.5 D Refraction stable ± 0.5 D within 2 years Myopia - 1.0 up to - 23.5 D (5 mm optic) - 1.0 up to - 15.5 D (6 mm optic) - 2.0 up to - 14.5 D (Veriflex) Hyperopia + 1.0 to +12.0 D Astigmatism 1 to 7.5 D University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010 Patient Selection for Verisyse/Veriflex Patient Selection for Verisyse/Veriflex AC-Depth > 3.0 mm (FDA 3.2 mm) Scotopic (Low Mesopic) Pupil Size 5 to 6 mm Endothelial Cell Count according to age >2.000 No other major systemic or ocular disorders AC-Depth > 3.0 mm (FDA 3.2 mm) Scotopic (Low Mesopic) Pupil Size 5 to 6 mm Endothelial Cell Count according to age >2.000 No other major systemic or ocular disorders Abib, JCRS 2001 University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010 General History General History pregnancy collagen-vascular dis. (rheumatism) diabetes mellitus thyroid dis. hyperplastic scars heart problems blood pressure pregnancy collagen-vascular dis. (rheumatism) diabetes mellitus thyroid dis. hyperplastic scars heart problems blood pressure asthma epilepsy kidney dis. liver dis. medication asthma epilepsy kidney dis. liver dis. medication University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010 Ocular History Ocular History Known ocular disorders (e.g.: Keratoconjunctivitis sicca or optic neuritis) Ocular trauma Squint Previous surgeries Family Hx of ocular disease Amblyopia Known ocular disorders (e.g.: Keratoconjunctivitis sicca or optic neuritis) Ocular trauma Squint Previous surgeries Family Hx of ocular disease Amblyopia

Transcript of Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc...

Page 1: Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc 2.0 Refraction Exclusion Criteria Preop Examination IOL-Power calculation using University

1

Patient SelectionIOL Power Calculation

Verisyse™ and VeriFlex™ Iris Claw

Technology for Correcting Refractive Errors in Phakic and Aphakic Eyes

ESCRS 2011 Intructional Course 61

Patient SelectionIOL Power Calculation

Verisyse™ and VeriFlex™ Iris Claw

Technology for Correcting Refractive Errors in Phakic and Aphakic Eyes

ESCRS 2011 Intructional Course 61

Josef RuckhoferJosef RuckhoferJosef RuckhoferJosef Ruckhofer

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Verisyse™ and VeriFlex™Verisyse™ and VeriFlex™

� Patient Selection� Refraction

� History

� General

� Ocular

� Social

� Exclusion Criteria

� Preop Examination

� ACD

� Pupil Size

� Planning Surgery

� Biometry� IOL-Power calculation using

Vericalc 2.0

� Patient Selection� Refraction

� History

� General

� Ocular

� Social

� Exclusion Criteria

� Preop Examination

� ACD

� Pupil Size

� Planning Surgery

� Biometry� IOL-Power calculation using

Vericalc 2.0

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Patient Selection for Verisyse/VeriflexPatient Selection for Verisyse/Veriflex

� Refraction� stable ± 0.5 D within 2 years

� Myopia

� - 1.0 up to - 23.5 D (5 mm optic)

� - 1.0 up to - 15.5 D (6 mm optic)

� - 2.0 up to - 14.5 D (Veriflex)

� Hyperopia

� + 1.0 to +12.0 D

� Astigmatism

� 1 to 7.5 D

� Refraction� stable ± 0.5 D within 2 years

� Myopia

� - 1.0 up to - 23.5 D (5 mm optic)

� - 1.0 up to - 15.5 D (6 mm optic)

� - 2.0 up to - 14.5 D (Veriflex)

� Hyperopia

� + 1.0 to +12.0 D

� Astigmatism

� 1 to 7.5 D

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Patient Selection for Verisyse/VeriflexPatient Selection for Verisyse/Veriflex

� AC-Depth� > 3.0 mm (FDA 3.2 mm)

� Scotopic (Low Mesopic) Pupil Size � 5 to 6 mm

� Endothelial Cell Count� according to age

� >2.000

� No other major systemic or ocular disorders

� AC-Depth� > 3.0 mm (FDA 3.2 mm)

� Scotopic (Low Mesopic) Pupil Size � 5 to 6 mm

� Endothelial Cell Count� according to age

� >2.000

� No other major systemic or ocular disorders

Abib, JCRS 2001

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

General HistoryGeneral History

� pregnancy

� collagen-vascular dis. (rheumatism)

� diabetes mellitus

� thyroid dis.

� hyperplastic scars

� heart problems

� blood pressure

� pregnancy

� collagen-vascular dis. (rheumatism)

� diabetes mellitus

� thyroid dis.

� hyperplastic scars

� heart problems

� blood pressure

� asthma

� epilepsy

� kidney dis.

� liver dis.

� medication

� asthma

� epilepsy

� kidney dis.

� liver dis.

� medication

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Ocular HistoryOcular History

� Known ocular disorders � (e.g.: Keratoconjunctivitis sicca or optic neuritis)

� Ocular trauma

� Squint

� Previous surgeries

� Family Hx of ocular disease

� Amblyopia

� Known ocular disorders � (e.g.: Keratoconjunctivitis sicca or optic neuritis)

� Ocular trauma

� Squint

� Previous surgeries

� Family Hx of ocular disease

� Amblyopia

Page 2: Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc 2.0 Refraction Exclusion Criteria Preop Examination IOL-Power calculation using University

2

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Social HistorySocial History

� Age

� Profession� far/near work, PC, taxi/bus driver ?

� Reading with or without spectacles ?

� CL – Wearer ? � type / tolerance / duration / last time wore

� Hobby � martial arts / golf / reading

� Age

� Profession� far/near work, PC, taxi/bus driver ?

� Reading with or without spectacles ?

� CL – Wearer ? � type / tolerance / duration / last time wore

� Hobby � martial arts / golf / reading

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

ScreeningScreening

Important:

Get patient‘s expectations down to a realistic level !

Important:

Get patient‘s expectations down to a realistic level !

What are your expectations ? What are your present problems ?

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Exclusion CriteriaExclusion Criteria

� Cataract

� RD or Hx of RD

� Pupil abnormalities

� Abnormal iris anatomy

� Corneal affections

� Glaucoma incl. Hx of ocular hypertension

� Uveitis

� Rubeosis

� (Maculo-/ retinopathy)

� Cataract

� RD or Hx of RD

� Pupil abnormalities

� Abnormal iris anatomy

� Corneal affections

� Glaucoma incl. Hx of ocular hypertension

� Uveitis

� Rubeosis

� (Maculo-/ retinopathy)

� Age < 18 J. (21)

� Scotop. pupil > optic diameter

� EC-Count < 2.000 /mm2

� AC depth < 3.0 mm

� Violent / dangerous life style -sports

� Age < 18 J. (21)

� Scotop. pupil > optic diameter

� EC-Count < 2.000 /mm2

� AC depth < 3.0 mm

� Violent / dangerous life style -sports

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Preop ExaminationPreop Examination

� Manifest refraction (BVD=12, CL-break !)

� Cycloplegic refraction

� Slitlamp

� IOP

� K-readings, (corneal topography)

� Endothelial cell count

� Retina in mydriasis

� Orthoptics (optional)

� Scotopic (low mesopic) pupil size

� Biometry, AC-Depth (IOL-Master)

� Manifest refraction (BVD=12, CL-break !)

� Cycloplegic refraction

� Slitlamp

� IOP

� K-readings, (corneal topography)

� Endothelial cell count

� Retina in mydriasis

� Orthoptics (optional)

� Scotopic (low mesopic) pupil size

� Biometry, AC-Depth (IOL-Master)

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

ACD: Distance to EndotheliumACD: Distance to Endothelium

antero-posterior

and peripheral

space at

various IOL power

section at -10 D section at -20 D

Budo C et al.: J Cataract Refract Surg 2000 Aug 26(8):1163-71

2.05

2.23

2.14

2.04

1.95

1.86

3.2 mm

3.3 mm

3.4 mm

ACDmin 1.5 mm

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Verisyse™ Phakic IOLVerisyse™ Phakic IOL

� Mean distance Verisyse™ - Endothelium

� Myopia: 2.05 mm ± 1.67 SD (min 1.75 – max 2.3)

� Hyperopia: 1.78 mm ± 0.2 SD (min 1.5 – max 2.0)

� Mean distance Verisyse™ - Endothelium

� Myopia: 2.05 mm ± 1.67 SD (min 1.75 – max 2.3)

� Hyperopia: 1.78 mm ± 0.2 SD (min 1.5 – max 2.0)

Scheimpflug Evaluations

(3 months postop)

myopia: 19 eyes

hyperopia: 6 eyes

Page 3: Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc 2.0 Refraction Exclusion Criteria Preop Examination IOL-Power calculation using University

3

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Verisyse™ Phakic IOLVerisyse™ Phakic IOL

� Mean distance Verisyse™ - Crystalline lens:

� Myopia: 0.56 mm ± 0.13 SD (min 0.35 – max 0.8)

� Hyperopia: 0.58 mm ± 0.18 SD (min 0.4 – max 0.8)

� Mean distance Verisyse™ - Crystalline lens:

� Myopia: 0.56 mm ± 0.13 SD (min 0.35 – max 0.8)

� Hyperopia: 0.58 mm ± 0.18 SD (min 0.4 – max 0.8)

Scheimpflug Evaluations

(3 months postop)

myopia: 19 eyes

hyperopia: 6 eyes

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

� Rosenbaum Card � not exact !

� Colvard Pupillometer � user-friendly, popular, ($ 1.500)

� Rosenbaum Card � not exact !

� Colvard Pupillometer � user-friendly, popular, ($ 1.500)

Pupil - Measurement DevicesPupil - Measurement Devices

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

� Computerized Systems:� Procyon 3000

� Wavefront-analyzer (eg. WASCA)

� Computerized Systems:� Procyon 3000

� Wavefront-analyzer (eg. WASCA)

Pupil - Measurement DevicesPupil - Measurement Devices

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Pupil SizePupil Size

� Large pupil diameter can be a contraindication forVerisyse™or VeriFlex™ phakic IOL, especially for patientswith relevant professions like Taxi drivers!

� Horizontal pupil diameter may be reduced by ~1 mm postop� Bootsma SJ et al. Evaluation of pupil dynamics after implantation of artisan phakic intraocular

lenses. J Refract Surg. 2006 Apr;22(4):367-71

� Dick HB et al. Change in pupil size after implantation of an iris-fixated toric phakic intraocular lens. J Cataract Refract Surg. 2005 Feb;31(2):302-7.

� In any case discuss the risks of glare and halos with the patient

� Large pupil diameter can be a contraindication forVerisyse™or VeriFlex™ phakic IOL, especially for patientswith relevant professions like Taxi drivers!

� Horizontal pupil diameter may be reduced by ~1 mm postop� Bootsma SJ et al. Evaluation of pupil dynamics after implantation of artisan phakic intraocular

lenses. J Refract Surg. 2006 Apr;22(4):367-71

� Dick HB et al. Change in pupil size after implantation of an iris-fixated toric phakic intraocular lens. J Cataract Refract Surg. 2005 Feb;31(2):302-7.

� In any case discuss the risks of glare and halos with the patient

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Planning SurgeryPlanning Surgery

� Pentacam (Oculus)� Pentacam (Oculus)

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Planning SurgeryPlanning Surgery

� Visante (Carl Zeiss Meditec)� Visante (Carl Zeiss Meditec)

Page 4: Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc 2.0 Refraction Exclusion Criteria Preop Examination IOL-Power calculation using University

4

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

VeriCalc™ 2.0VeriCalc™ 2.0

Planning Refractive Success

for Verisyse™ and VeriFlex™

Planning Refractive Success

for Verisyse™ and VeriFlex™

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

VeriCalc™ 2.0VeriCalc™ 2.0

� Assistant for determining the correct power of Verisyse™ and VeriFlex™ phakic IOL

� Developed in collaboration with Wolfgang Haigis,PhD, University Eye Clinic Würzburg

� Based on the “Refractive Vergence Formula”

� Valid for phakic and pseudophakic eyes with no or slight astigmatism (< 2D)

� Offers an inter-active choice of target refractions forvarious IOL power

� Assistant for determining the correct power of Verisyse™ and VeriFlex™ phakic IOL

� Developed in collaboration with Wolfgang Haigis,PhD, University Eye Clinic Würzburg

� Based on the “Refractive Vergence Formula”

� Valid for phakic and pseudophakic eyes with no or slight astigmatism (< 2D)

� Offers an inter-active choice of target refractions forvarious IOL power

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

VeriCalc™ 2.0VeriCalc™ 2.0

� Displays safety distances to the endothelium based on empiric evaluations

� Data Import from IOL - Master possible

� No patient data bank

� Printout of calculation for patient file possible

� Displays safety distances to the endothelium based on empiric evaluations

� Data Import from IOL - Master possible

� No patient data bank

� Printout of calculation for patient file possible

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

VeriCalc™ 2.0 - Data Required For CalculationVeriCalc™ 2.0 - Data Required For Calculation

� Subjective Refraction � contact lens break!

� Calculation refers to spherical equivalent

� Astigmatism ≤ 2 D

� Anterior Chamber Depth� preferred: IOL Master or US in Immersion Mode

� ACD from endothelium? Add pachymetry for calculation!

� Keratometer Readings � K-Index correct ?

� Low Mesopic Pupil diameter � Choice of the Optical Diameter of the lens

� Subjective Refraction � contact lens break!

� Calculation refers to spherical equivalent

� Astigmatism ≤ 2 D

� Anterior Chamber Depth� preferred: IOL Master or US in Immersion Mode

� ACD from endothelium? Add pachymetry for calculation!

� Keratometer Readings � K-Index correct ?

� Low Mesopic Pupil diameter � Choice of the Optical Diameter of the lens

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Confirm Settings!

VeriCalc™ 2.0 - StartVeriCalc™ 2.0 - Start

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

VeriCalc™ 2.0 - Import Patient DataVeriCalc™ 2.0 - Import Patient Data

Page 5: Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc 2.0 Refraction Exclusion Criteria Preop Examination IOL-Power calculation using University

5

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Patient Data

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Patient Data

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Patient Data

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Patient Data

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Calculation

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Calculation

Page 6: Patient Selection Refraction IOL Power Calculation...Biometry IOL-Power calculation using Vericalc 2.0 Refraction Exclusion Criteria Preop Examination IOL-Power calculation using University

6

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Calculation

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Calculation

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Calculation

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

PrintoutPrintout

� The final choice of the power for Verisyse™ and VeriFlex™ Phakic IOL depends on various factors and is the responsibility of the physician implanting the lens

� The final choice of the power for Verisyse™ and VeriFlex™ Phakic IOL depends on various factors and is the responsibility of the physician implanting the lens

University Eye Clinic Salzburg, Austria Verisyse and Veriflex Iris Claw Technology ESCRS 2010

Thank you for your attention !Thank you for your attention !